ArticlePlant biotechnology journal2026
Metabolic Reprogramming of a Phenolic Acid by a Plant P450 Monooxygenase Reverses Bacterial Immunosuppression.
Article in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Soil acidification often exacerbates plant diseases caused by soil-borne pathogens like Ralstonia solanacearum, but the underlying molecular mechanisms remain elusive. This study unveils a sophisticated metabolic game in the tobacco-R. solanacearum pathosystem, where the pathogen manipulates host metabolism to suppress immunity, and the plant counteracts by enzymatically reprogramming a key metabolic signal. Using multi-omics approaches, we discovered that R. solanacearum infection induces a significant accumulation of veratric acid (VA) in tobacco. We demonstrated that VA acts as a potent immunosuppressant rather than a nutrient for the pathogen. It broadly inhibits plant pattern-triggered immunity, including flg22-induced ROS burst, and transcriptionally represses a suite of nucleotide-binding leucine-rich repeat (NLR) receptors, crucially including NtG28897 (NtTAO1). Silencing of NtTAO1 confirmed its pivotal role in resistance against Tobacco Mosaic Virus (TMV). Facing this metabolic sabotage, tobacco engages a counter-defence mechanism. We identified a specific cytochrome P450 monooxygenase (CYP86A22) that catalyses the conversion of the disease-promoting VA into vanillic acid (VanA). Transient overexpression of this P450 in Nicotiana benthamiana enhanced the in vivo conversion of VA to VanA. Crucially, this enzymatic conversion conferred strong resistance against TMV, whereas the P450 or VA alone did not. Our findings reveal a novel plant immune strategy 'metabolic signal reprogramming' where a P450 enzyme detoxifies a susceptibility metabolite into a defensive compound. This work provides a new paradigm for plant-pathogen interactions and identifies promising targets for metabolic engineering or green chemical strategies to achieve sustainable disease control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.